Background: Vancomycin is an antibiotic of growing importance in the treatment of hospital infections, with particular emphasis on its value in the fight against methicillin-resistant Staphylococcus aureus. However its usage profile must be evaluated to assure maximum benefit and minimum risk.
Findings: A cross-sectional retrospective study was carried out among inpatients that received vancomycin in a Brazilian quaternary hospital.